Syndax Pharmaceuticals, Inc

(NASDAQ:SNDX)

Latest On Syndax Pharmaceuticals, Inc (SNDX):

Date/Time Type Description Signal Details
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01N/A
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 02:38 ESTNewsSyndax Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-04 02:40 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 16:35 ESTNewsSyndax Pharmaceuticals: 2023 Is A Pivotal YearN/A
2023-03-01 01:25 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04N/A
2023-02-27 19:50 ESTNewsSyndax Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-12 14:22 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-12-17 03:56 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & ExpositionN/A
2022-12-12 19:48 ESTNewsKura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidatesN/A
2022-12-10 16:27 ESTNewsSyndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain ProspectN/A
2022-12-07 20:58 ESTNewsSyndax Pharmaceuticals prices $150M offeringN/A
2022-12-07 01:27 ESTNewsSyndax Pharma to sell $150M stock in public offeringN/A
2022-12-05 14:27 ESTNewsSyndax receives breakthrough therapy tag for revumenib to treat acute leukemiaN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call TranscriptN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 08:33 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidanceN/A
2022-11-02 23:19 ESTNewsSyndax Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62N/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 07:37 ESTNewsSyndax Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-13 12:56 ESTNewsKeith Goldan joins Syndax Pharmaceuticals as CFON/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 16:51 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.63N/A
2022-05-09 00:26 ESTNewsSyndax Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-08 05:11 ESTNewsSyndax Pharmaceuticals: Cash-Rich With 2 Promising DrugsN/A
2022-03-25 00:25 ESTNewsSyndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare ConferenceN/A
2022-03-02 06:49 ESTNewsSyndax appoints former Alnylam executive as new medical chiefN/A
2022-03-02 06:49 ESTNewsSyndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92MN/A
2022-03-02 06:48 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 18:56 ESTNewsSyndax Pharmaceuticals Q4 Earnings PreviewN/A
2022-01-29 06:36 ESTNewsSyndax Pharmaceuticals (SNDX) Investor Presentation - SlideshowN/A
2021-12-23 00:22 ESTNewsSyndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemiaN/A
2021-12-16 14:02 ESTNewsSyndax Pharma raises $75M via stock offeringN/A
2021-12-15 18:28 ESTNewsSyndax Pharmaceuticals drops 6% following underwritten stock offeringN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals EPS misses by $0.35, misses on revenueN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-14 18:13 ESTNewsSyndax Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-04 16:35 ESTNewsSyndax Pharma falls after updating early-stage data for leukemia therapyN/A
2021-10-05 15:59 ESTNewsSyndax Pharma CFO Daphne Karydas to resign to pursue another opportunityN/A
2021-09-28 02:06 ESTNewsIncyte and Syndax in pact for xatilimab targeting immune-related conditionsN/A
2021-08-10 12:01 ESTNewsSyndax Pharmaceuticals EPS beats by $0.28, beats on revenueN/A
2021-08-10 12:00 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 11:59 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-22 02:04 ESTNewsSyndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 DataN/A
2021-07-22 02:02 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 01:35 ESTNewsSyndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613N/A

About Syndax Pharmaceuticals, Inc (SNDX):

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Syndax Pharmaceuticals, Inc
  • Symbol SNDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2016-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.syndax.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 634.74
  • Price/Book (Most Recent Quarter) 4.43
  • Enterprise Value Revenue 542.55
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.19
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.47
  • Operating Margin -4708%
  • Return on Assets -25%
  • Return on Equity -52%
  • Revenue 1.52 million
  • Earnings Per Share -$2.36
  • Revenue Per Share $0.04
  • Gross Profit 1.52 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.16 billion
  • EBITDA -67280000
  • PE Ratio -125.39
  • Analyst Target Price $32.14
  • Book Value Per Share $5.27
View More

Share Statistics

  • Shares Outstanding 48.24 million
  • Shares Float 42.95 million
  • % Held by Insiders 645%
  • % Held by Institutions 78.88%
  • Shares Short 4.93 million
  • Shares Short Prior Month 4.93 million
  • Short Ratio 9.27
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.84
  • 52 Week High $27.12
  • 52 Week Low $8.18
  • 50 Day Moving Average 22.33
  • 200 Day Moving Average 20.55
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Syndax Pharmaceuticals, Inc (SNDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$380000-$0.44-$0.5113.23%
2020-09-302020-11-02$N/A-$0.46-$0.43-6.75%
2020-06-302020-08-06$N/A-$0.42-$0.444.76%
2020-03-312020-05-07$379000-$0.56-$0.53-6.65%
2019-12-312020-03-03$380000-$0.44-$0.43-1.31%
2019-09-302019-11-07$379000-$0.41-$0.4813.92%
2019-06-302019-08-07$379000-$0.47-$0.470.76%
2019-03-312019-05-06$379000-$0.53-$0.554.14%
2018-12-312019-03-07$379000-$0.70-$0.64-9.43%
2018-09-302018-11-05$379000-$0.68-$0.7610.21%
2018-06-302018-08-07$379000-$0.74-$0.8916.94%
2018-03-312018-05-08$379000-$0.79-$0.9517.15%
2017-12-312018-03-05$1.19 million-$0.80-$0.77-3.67%
2017-09-302017-11-07$305000-$0.68-$0.8216.63%
2017-06-302017-08-10$305000-$0.70-$0.8214.83%
2017-03-312017-05-08$305000-$0.71-$0.710.56%
2016-12-312017-03-02$305000-$0.59-$0.7419.79%
2016-09-302016-11-10$305000-$0.84-$0.82-2.78%
2016-06-302016-08-09$305000-$0.47-$0.5412.18%
2016-03-312016-05-16$305000-$0.73-$0.48-52.22%

Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Syndax Pharmaceuticals, Inc (SNDX) Chart:

Syndax Pharmaceuticals, Inc (SNDX) News:

Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Syndax Pharmaceuticals, Inc (SNDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-1910CALL0 00TRUE00
2025-12-1920CALL0 01200.97TRUE00
2025-12-1930CALL0 0972.49TRUE00
2025-12-1940CALL0 0778.63TRUE00
2025-12-1950CALL0 0673.17TRUE00
2025-12-1960CALL0 0589.22TRUE00
2025-12-1970CALL0 0519.48TRUE00
2025-12-1980CALL0 0459.78TRUE00
2025-12-1990CALL0 0431.29TRUE00
2025-12-191010.47CALL0 350TRUE00
2025-12-19118.71CALL0 10TRUE00
2025-12-19128.28CALL0 60TRUE00
2025-12-19136.95CALL0 170TRUE00
2025-12-19146.5CALL0 3700TRUE00
2025-12-19154.75CALL0 1200TRUE00
2025-12-19163.5CALL0 330TRUE00
2025-12-19172.6CALL0 3090TRUE00
2025-12-19182.92CALL0 17450TRUE00
2025-12-19192.2CALL0 3110TRUE00
2025-12-19201CALL1 238276.96TRUE-0.5-0.33
2025-12-19211.1CALL0 82570.27FALSE00
2025-12-19221CALL0 129893.22FALSE00
2025-12-19230.35CALL10 117112.44FALSE-0.02-0.05
2025-12-19240.35CALL0 1189.44FALSE00
2025-12-19250.3CALL0 1332298.01FALSE00
2025-12-19260.25CALL0 3233.05FALSE00
2025-12-19270CALL0 0549.47FALSE00
2025-12-19280CALL0 0377.61FALSE00
2025-12-19290CALL0 0412.04FALSE00
2025-12-19300.05CALL0 23303.25FALSE00
2025-12-19310CALL0 0655.5FALSE00
2025-12-19320CALL0 0672.29FALSE00
2025-12-19330CALL0 0688.27FALSE00
2025-12-19340CALL0 0502.86FALSE00
2025-12-19350.05CALL0 1718.08FALSE00
2025-12-1910PUT0 00FALSE00
2025-12-1920PUT0 00FALSE00
2025-12-1930PUT0 00FALSE00
2025-12-1940PUT0 00FALSE00
2025-12-1950PUT0 01467.11FALSE00
2025-12-1960PUT0 00FALSE00
2025-12-1970PUT0 01046.72FALSE00
2025-12-1980PUT0 0880.87FALSE00
2025-12-1990PUT0 0821.71FALSE00
2025-12-19100.6PUT0 264322.1FALSE00
2025-12-19110.05PUT0 16329.61FALSE00
2025-12-19120.05PUT0 144219.09FALSE00
2025-12-19130.11PUT0 10282.49FALSE00
2025-12-19140.13PUT0 302307.67FALSE00
2025-12-19150.15PUT0 331421.9FALSE00
2025-12-19160.2PUT0 200338.91FALSE00
2025-12-19170.15PUT20 90116.28FALSE0.150
2025-12-19180.3PUT0 526101.39FALSE00
2025-12-19190.55PUT1 144110.02FALSE0.060.12
2025-12-19200.85PUT2 1999.81FALSE0.050.06
2025-12-19211.5PUT0 790.75TRUE00
2025-12-19221.8PUT0 4146.74TRUE00
2025-12-19234PUT0 1116.56TRUE00
2025-12-19240PUT0 0117.02TRUE00
2025-12-19250PUT0 0151.95TRUE00
2025-12-19260PUT0 00TRUE00
2025-12-19270PUT0 00TRUE00
2025-12-19280PUT0 0161.21TRUE00
2025-12-19290PUT0 0174.45TRUE00
2025-12-19300PUT0 0187.01TRUE00
2025-12-19310PUT0 0181.44TRUE00
2025-12-19320PUT0 00TRUE00
2025-12-19330PUT0 00TRUE00
2025-12-19340PUT0 00TRUE00
2025-12-19350PUT0 00TRUE00
2026-01-1610CALL0 00TRUE00
2026-01-162.50CALL0 10TRUE00
2026-01-1640CALL0 00TRUE00
2026-01-1655.13CALL0 130TRUE00
2026-01-1660CALL0 00TRUE00
2026-01-167.511.5CALL0 1450TRUE00
2026-01-1696.81CALL0 10TRUE00
2026-01-161011.13CALL0 7310TRUE00
2026-01-16117.11CALL0 100TRUE00
2026-01-1612.57CALL0 52710TRUE00
2026-01-16147CALL0 3270TRUE00
2026-01-16155.63CALL2 294680.02TRUE-0.42-0.07
2026-01-16165CALL0 2250TRUE00
2026-01-1617.54.1CALL0 144582.13TRUE00
2026-01-16192.1CALL0 81103.49TRUE00
2026-01-16202CALL9 165472.33TRUE-0.05-0.02
2026-01-16212CALL0 590.46FALSE00
2026-01-1622.51.2CALL0 66294.03FALSE00
2026-01-16240CALL0 0187.37FALSE00
2026-01-16250.64CALL8 224880.49FALSE-0.03-0.04
2026-01-16260CALL0 0123.1FALSE00
2026-01-16270CALL0 0170.83FALSE00
2026-01-16280CALL0 0177.33FALSE00
2026-01-16290CALL0 0138.05FALSE00
2026-01-16300.2CALL1 19585.41FALSE-0.08-0.29
2026-01-16310CALL0 0138.7FALSE00
2026-01-16320CALL0 0177.62FALSE00
2026-01-16330CALL0 0320.81FALSE00
2026-01-16340CALL0 0245.42FALSE00
2026-01-16350.12CALL0 118142.92FALSE00
2026-01-1610PUT0 00FALSE00
2026-01-162.50PUT0 0410.93FALSE00
2026-01-1640PUT0 00FALSE00
2026-01-1650.36PUT0 8567.69FALSE00
2026-01-1660PUT0 0486.24FALSE00
2026-01-167.50.05PUT0 5375.79FALSE00
2026-01-1690.31PUT0 1355.48FALSE00
2026-01-16100.05PUT0 516147.36FALSE00
2026-01-16110.05PUT0 11259.28FALSE00
2026-01-1612.50.6PUT0 3994223.47FALSE00
2026-01-16140.35PUT0 88155.42FALSE00
2026-01-16150.25PUT0 922123.19FALSE00
2026-01-16162.24PUT0 14129.36FALSE00
2026-01-1617.50.65PUT0 23077.03FALSE00
2026-01-16190PUT0 0203.05FALSE00
2026-01-16202.09PUT0 41173.68FALSE00
2026-01-16210PUT0 0181.73TRUE00
2026-01-1622.53.9PUT0 768.51TRUE00
2026-01-16240PUT0 079.64TRUE00
2026-01-16250PUT0 083.14TRUE00
2026-01-16260PUT0 089.17TRUE00
2026-01-16270PUT0 085.26TRUE00
2026-01-16280PUT0 00TRUE00
2026-01-16290PUT0 00TRUE00
2026-01-16300PUT0 083.92TRUE00
2026-01-16310PUT0 0103.56TRUE00
2026-01-16320PUT0 00TRUE00
2026-01-16330PUT0 099.24TRUE00
2026-01-16340PUT0 0103.93TRUE00
2026-01-16350PUT0 00TRUE00
2026-04-1710CALL0 0276.48TRUE00
2026-04-1720CALL0 0199.2TRUE00
2026-04-1730CALL0 0156.69TRUE00
2026-04-1740CALL0 0126.57TRUE00
2026-04-1750CALL0 00TRUE00
2026-04-1760CALL0 00TRUE00
2026-04-1777.8CALL0 10TRUE00
2026-04-1780CALL0 0102.41TRUE00
2026-04-1790CALL0 0104.09TRUE00
2026-04-17107.9CALL0 57387.63TRUE00
2026-04-17115.8CALL0 776.79TRUE00
2026-04-17128.2CALL0 573.65TRUE00
2026-04-17137.5CALL0 10276.83TRUE00
2026-04-17145.19CALL0 973.12TRUE00
2026-04-17155.6CALL0 1540TRUE00
2026-04-17165.2CALL0 43272.73TRUE00
2026-04-17174.7CALL0 27773.12TRUE00
2026-04-17184.3CALL0 15374.59TRUE00
2026-04-17194.1CALL0 4978.16TRUE00
2026-04-17203.8CALL2 14674.91TRUE0.320.09
2026-04-17214CALL0 287.55FALSE00
2026-04-17222.68CALL0 3179.9FALSE00
2026-04-17232.2CALL0 176.39FALSE00
2026-04-17242.3CALL0 175.33FALSE00
2026-04-17251.73CALL0 23974.63FALSE00
2026-04-17261.49CALL0 2118.06FALSE00
2026-04-17270CALL0 0118.82FALSE00
2026-04-17280CALL0 0121.37FALSE00
2026-04-17290CALL0 0121.5FALSE00
2026-04-17301.3CALL0 147138.29FALSE00
2026-04-17310CALL0 0125.22FALSE00
2026-04-17321.2CALL0 1124.58FALSE00
2026-04-17330CALL0 0123.7FALSE00
2026-04-17341.05CALL0 1129.19FALSE00
2026-04-17350CALL0 0111.95FALSE00
2026-04-1710PUT0 0262.08FALSE00
2026-04-1720PUT0 00FALSE00
2026-04-1730PUT0 00FALSE00
2026-04-1740PUT0 00FALSE00
2026-04-1750PUT0 0820.2FALSE00
2026-04-1760PUT0 0547.69FALSE00
2026-04-1770PUT0 0449.32FALSE00
2026-04-1780PUT0 0386.8FALSE00
2026-04-1790PUT0 0340.76FALSE00
2026-04-17100.9PUT0 333142.6FALSE00
2026-04-17110.9PUT0 43167.17FALSE00
2026-04-17122.15PUT0 13156.21FALSE00
2026-04-17131.4PUT0 63139.15FALSE00
2026-04-17140.93PUT0 111109.27FALSE00
2026-04-17151.1PUT0 26139.55FALSE00
2026-04-17161.3PUT0 314116.02FALSE00
2026-04-17172.3PUT0 58148.17FALSE00
2026-04-17182.8PUT0 166.93FALSE00
2026-04-17192.5PUT0 20980.27FALSE00
2026-04-17203.43PUT0 758.6FALSE00
2026-04-17214.5PUT0 364.77TRUE00
2026-04-17225.3PUT0 174.99TRUE00
2026-04-17230PUT0 077.96TRUE00
2026-04-17240PUT0 074.9TRUE00
2026-04-17250PUT0 075.39TRUE00
2026-04-17260PUT0 075.25TRUE00
2026-04-17270PUT0 074.47TRUE00
2026-04-17280PUT0 076.65TRUE00
2026-04-17290PUT0 077.22TRUE00
2026-04-17300PUT0 074.69TRUE00
2026-04-17310PUT0 081.01TRUE00
2026-04-17320PUT0 077.59TRUE00
2026-04-17330PUT0 079.38TRUE00
2026-04-17340PUT0 079.33TRUE00
2026-04-17350PUT0 082.25TRUE00
2026-07-1750CALL0 096.23TRUE00
2026-07-1790CALL0 081.2TRUE00
2026-07-17100CALL0 071.13TRUE00
2026-07-17110CALL0 069.65TRUE00
2026-07-17120CALL0 077.83TRUE00
2026-07-17130CALL0 076.22TRUE00
2026-07-17140CALL0 077.69TRUE00
2026-07-17150CALL0 075.55TRUE00
2026-07-17160CALL0 074.99TRUE00
2026-07-17170CALL0 075.66TRUE00
2026-07-17180CALL0 073.66TRUE00
2026-07-17190CALL0 074.72TRUE00
2026-07-17204.7CALL0 878.51TRUE00
2026-07-17210CALL0 076.15FALSE00
2026-07-17224.5CALL5 079.93FALSE4.50
2026-07-17233.35CALL0 573.08FALSE00
2026-07-17243.4CALL0 3375.53FALSE00
2026-07-17253.07CALL0 674.38FALSE00
2026-07-17262.6CALL0 7168.01FALSE00
2026-07-17270CALL0 060.18FALSE00
2026-07-17280CALL0 065.29FALSE00
2026-07-17292.05CALL0 175.25FALSE00
2026-07-17301.85CALL0 1110.77FALSE00
2026-07-17311.7CALL0 1115.36FALSE00
2026-07-17320CALL0 089.02FALSE00
2026-07-17331.7CALL0 2112.89FALSE00
2026-07-17340CALL0 0115.46FALSE00
2026-07-17350CALL0 0117.91FALSE00
2026-07-1750PUT0 0197.99FALSE00
2026-07-1790PUT0 080.35FALSE00
2026-07-17100PUT0 073.02FALSE00
2026-07-17110PUT0 0126.8FALSE00
2026-07-17120PUT0 0132.48FALSE00
2026-07-17130PUT0 0122.38FALSE00
2026-07-17140PUT0 0111.8FALSE00
2026-07-17150PUT0 0114.09FALSE00
2026-07-17160PUT0 0115.48FALSE00
2026-07-17173.1PUT0 174.45FALSE00
2026-07-17183.2PUT0 366.84FALSE00
2026-07-17193.7PUT0 173.76FALSE00
2026-07-17200PUT0 068.49FALSE00
2026-07-17210PUT0 064.58TRUE00
2026-07-17220PUT0 061.06TRUE00
2026-07-17230PUT0 065.05TRUE00
2026-07-17240PUT0 074.13TRUE00
2026-07-17250PUT0 073.15TRUE00
2026-07-17260PUT0 073.39TRUE00
2026-07-17270PUT0 073.28TRUE00
2026-07-17280PUT0 073.66TRUE00
2026-07-17290PUT0 073.74TRUE00
2026-07-17300PUT0 072.62TRUE00
2026-07-17310PUT0 074.77TRUE00
2026-07-17320PUT0 074.93TRUE00
2026-07-17330PUT0 075.81TRUE00
2026-07-17340PUT0 073.51TRUE00
2026-07-17350PUT0 075.95TRUE00
2027-01-1530CALL0 076.93TRUE00
2027-01-1550CALL0 00TRUE00
2027-01-15813CALL0 1779.08TRUE00
2027-01-151011.27CALL0 2073.61TRUE00
2027-01-15139.25CALL2 16063.55TRUE9.250
2027-01-15158.5CALL0 14278.34TRUE00
2027-01-15176CALL0 1070.39TRUE00
2027-01-15206.33CALL0 10873.46TRUE00
2027-01-15225.62CALL0 4069.52FALSE00
2027-01-15255CALL0 1371.14FALSE00
2027-01-15271.85CALL0 6571.11FALSE00
2027-01-15302CALL0 2568.59FALSE00
2027-01-15320CALL0 069.91FALSE00
2027-01-15350CALL0 071.93FALSE00
2027-01-15370CALL0 0101.01FALSE00
2027-01-15402.23CALL0 275.73FALSE00
2027-01-1530PUT0 0163.37FALSE00
2027-01-1550PUT0 00FALSE00
2027-01-1580PUT0 0136.53FALSE00
2027-01-15100PUT0 0160.91FALSE00
2027-01-15133.7PUT0 5121.73FALSE00
2027-01-15154.45PUT0 1566.06FALSE00
2027-01-15170PUT0 070FALSE00
2027-01-15205.5PUT0 174.18FALSE00
2027-01-15220PUT0 070.85TRUE00
2027-01-15250PUT0 070.24TRUE00
2027-01-15270PUT0 070.7TRUE00
2027-01-15300PUT0 066.89TRUE00
2027-01-15320PUT0 071.67TRUE00
2027-01-15350PUT0 071.68TRUE00
2027-01-15370PUT0 069.45TRUE00
2027-01-15400PUT0 073.9TRUE00
2028-01-2130CALL0 0104.31TRUE00
2028-01-2150CALL0 068.64TRUE00
2028-01-2180CALL0 072.09TRUE00
2028-01-21109.46CALL0 10775.28TRUE00
2028-01-21136CALL0 174.49TRUE00
2028-01-21150CALL0 072.43TRUE00
2028-01-21170CALL0 069.75TRUE00
2028-01-21208.53CALL50 5370.32TRUE8.530
2028-01-21220CALL0 070.94FALSE00
2028-01-21250CALL0 068.96FALSE00
2028-01-21270CALL0 068.67FALSE00
2028-01-21305.88CALL50 5168.69FALSE5.880
2028-01-21320CALL0 068.61FALSE00
2028-01-21350CALL0 068.58FALSE00
2028-01-21370CALL0 071.09FALSE00
2028-01-21400CALL0 070.26FALSE00
2028-01-2130PUT0 00FALSE00
2028-01-2150PUT0 00FALSE00
2028-01-2180PUT0 0136.68FALSE00
2028-01-21102.71PUT0 3133.66FALSE00
2028-01-21133.1PUT0 7078.49FALSE00
2028-01-21150PUT0 068.74FALSE00
2028-01-21176.68PUT0 164.36FALSE00
2028-01-21200PUT0 067.66FALSE00
2028-01-21220PUT0 063.45TRUE00
2028-01-21250PUT0 067.5TRUE00
2028-01-21270PUT0 064.41TRUE00
2028-01-21300PUT0 066.05TRUE00
2028-01-21320PUT0 069.39TRUE00
2028-01-21350PUT0 070.08TRUE00
2028-01-21370PUT0 068.77TRUE00
2028-01-21400PUT0 068.5TRUE00

Latest SNDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST3$15.6
Jun 13, 2022 7:59 PM EST4$15.6
Jun 13, 2022 7:59 PM EST1$15.6
Jun 13, 2022 7:59 PM EST100$15.61
Jun 13, 2022 7:59 PM EST45$15.61

Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm
2020-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm
2019-04-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm
2020-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm
2018-11-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm
2018-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm
2018-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm
2019-03-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm
2019-03-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm
2019-09-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm
2019-09-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm
2020-05-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm
2018-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm
2019-03-1810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm
2019-08-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm
2020-04-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm
2019-09-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm
2018-11-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm
2018-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm
2018-06-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm

Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 645%
Institutional Ownership: 7888%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-04-03Peter OrdentlichChief Scientific OfficerSell7,500.0015.00112,500.000.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2020-07-06Michael L. MeyersSVP, Chief Medical OfficerBuy3,500.0010,730.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-11-04Michael A MetzgerPresident and COOBuy100,000.007.20720,000.00117,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-09Briggs MorrisonChief Executive OfficerBuy13,200.007.5699,726.0013,200.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2020-02-12Michael A MetzgerPresident and COOBuy15,000.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-11-04Michael A MetzgerPresident and COOSell100,000.0020.312,031,410.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-13Briggs MorrisonChief Executive OfficerBuy7,200.007.2952,516.8020,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2018-10-30Michael L. MeyersSVP, Chief Medical OfficerBuy200.004.79958.002,398.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-10-10Briggs MorrisonChief Executive OfficerBuy11,000.005.4059,400.0031,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-04Briggs MorrisonChief Executive OfficerBuy12,500.008.00100,000.0043,900.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy1,000.004.934,930.007,118.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy104.004.87506.487,222.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2018-04-03Peter OrdentlichChief Scientific OfficerBuy7,500.003.0823,100.007,500.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm